Related content
Research Output
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generation
Research output: Contribution to journal › Article
Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests
Research output: Contribution to journal › Letter
Andexanet alfa for the reversal of factor Xa inhibitors
Research output: Contribution to journal › Review article
Clotting test results correlate better with DOAC concentrations when expressed as a "Correction Ratio"; results before/after extraction with the DOAC Stop reagent
Research output: Contribution to journal › Article
Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTE
Research output: Contribution to journal › Article
Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application
Research output: Contribution to journal › Article
The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs
Research output: Contribution to journal › Letter
Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma
Research output: Contribution to journal › Article
Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' reply
Research output: Contribution to journal › Letter
Impact of the Direct Oral Anticoagulants on Activated Clotting Time
Research output: Contribution to journal › Article
Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
Research output: Contribution to journal › Article
Suivi biologique des patients sous nouveaux anticoagulants oraux: qui, quand, comment ?
Research output: Contribution to journal › Review article
An update on laboratory assessment for direct oral anticoagulants (DOACs)
Research output: Contribution to journal › Review article
Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: Assessment of the performance of a rapid centrifugation method
Research output: Contribution to journal › Article
Prizes
56th ASH Annual Meeting and Exposition - Abstract Achievement Award
Prize: Prize (including medals and awards)
XXIV Congress of the ISTH - Young Investigators Awards
Prize: Prize (including medals and awards)
Eberhard F. Mammen Young Investigator Award 2019
Prize: National/international honour
55th ASH Annual Meeting and Exposition - Abstract Achievement Award
Prize: Prize (including medals and awards)
58th Annual SSC Meeting of the ISTH - Young Investigators Awards
Prize: Prize (including medals and awards)
Activities
26th International Congress on Thrombosis
Activity: Participating in or organising an event types › Participation in conference
Laboratory testing in patients treated with DOACs: a practical guide for clinicians
Activity: Talk or presentation types › Oral presentation
Interference of DOACs in coagulation tests
Activity: Talk or presentation types › Oral presentation
The Namur Thrombosis and Hemostasis Center A gathering of experts from laboratory, clinical and regulatory field
Activity: Talk or presentation types › Invited talk
Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES
Activity: Talk or presentation types › Oral presentation
Educational I - Should we measure DOACs?
Activity: Talk or presentation types › Oral presentation